{"DataElement":{"publicId":"6438206","version":"1","preferredName":"Esophageal Squamous Cell Carcinoma AJCC Edition 8 Pathologic Group Stage","preferredDefinition":"Pathologic stage group based on the combination of T, N, and M categories and relevant prognostic factors for esophageal squamous cell carcinoma, using AJCC Ed. 8 criteria.","longName":"ESCC_AJC8_PTH_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6438186","version":"1","preferredName":"Esophageal Squamous Cell Carcinoma Pathologic Stage Grouping","preferredDefinition":"A squamous cell carcinoma arising from the esophagus.  It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30.  The median age is around 65 in both males and females.  It is located mostly in the middle and lower third of the esophagus.  Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described.  The microscopic features are the same as in other squamous cell carcinomas.  Any degree of differentiation may occur, and variation within a single tumor is common.  The prognosis is poor._Caused by or altered by or manifesting disease or pathology._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"6438168v1.0:2230144v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6438168","version":"1","preferredName":"Esophageal Squamous Cell Carcinoma","preferredDefinition":"A squamous cell carcinoma arising from the esophagus.  It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30.  The median age is around 65 in both males and females.  It is located mostly in the middle and lower third of the esophagus.  Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described.  The microscopic features are the same as in other squamous cell carcinomas.  Any degree of differentiation may occur, and variation within a single tumor is common.  The prognosis is poor.","longName":"C4024","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal Squamous Cell Carcinoma","conceptCode":"C4024","definition":"A squamous cell carcinoma arising from the esophagus.  It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30.  The median age is around 65 in both males and females.  It is located mostly in the middle and lower third of the esophagus.  Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described.  The microscopic features are the same as in other squamous cell carcinomas.  Any degree of differentiation may occur, and variation within a single tumor is common.  The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A4045F-27AA-42A2-E053-F662850AA860","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230144","version":"1","preferredName":"Pathologic Stage Grouping","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25610:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CCE-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"76A3B0F8-D580-5D80-E053-F662850AD3A2","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"TAYLORT","dateModified":"2018-10-04","changeDescription":"9/24/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6438057","version":"1","preferredName":"Esophageal Squamous Cell Carcinoma American Joint Committee on Cancer Edition 8 Pathologic Group Stage","preferredDefinition":"A term that refers to the pathologic staging of esophageal squamous cell carcinoma according to the American Joint Committee on Cancer, 8th edition._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6438057v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IVB","valueDescription":"Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438059","version":"1","preferredName":"Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438059","preferredDefinition":"Stage IVB includes: Any T, Any N, M1, Any G, Tumor location: Any. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133542","definition":"Stage IVB includes: Any T, Any N, M1, Any G, Tumor location: Any. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-D9BD-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A20948-D9D6-505B-E053-F662850A72D4","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438061","version":"1","preferredName":"Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438061","preferredDefinition":"Stage IVA includes: (T4a, N2, M0, Any G, Tumor location: Any); (T4b, N0-2, M0, Any G, Tumor location: Any); (Any T, N3, M0, Any G, Tumor location: Any). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133541","definition":"Stage IVA includes: (T4a, N2, M0, Any G, Tumor location: Any); (T4b, N0-2, M0, Any G, Tumor location: Any); (Any T, N3, M0, Any G, Tumor location: Any). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-D9E3-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A20948-D9FC-505B-E053-F662850A72D4","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438063","version":"1","preferredName":"Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438063","preferredDefinition":"Stage IIIB includes: (T2, N2, M0, Any G, Tumor location: Any); (T3, N1-2, M0, Any G, Tumor location: Any); (T4a, N0-1, M0, Any G, Tumor location: Any). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133538","definition":"Stage IIIB includes: (T2, N2, M0, Any G, Tumor location: Any); (T3, N1-2, M0, Any G, Tumor location: Any); (T4a, N0-1, M0, Any G, Tumor location: Any). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DA09-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A20948-DA22-505B-E053-F662850A72D4","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438065","version":"1","preferredName":"Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438065","preferredDefinition":"Stage IIIA includes: (T1, N2, M0, Any G, Tumor location: Any); (T2, N1, M0, Any G, Tumor location: Any). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133537","definition":"Stage IIIA includes: (T1, N2, M0, Any G, Tumor location: Any); (T2, N1, M0, Any G, Tumor location: Any). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DA2F-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A20948-DA48-505B-E053-F662850A72D4","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438067","version":"1","preferredName":"Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438067","preferredDefinition":"Stage IIB includes: (T3, N0, M0, G2-3, Tumor location: Upper/middle); (T3, N0, M0, GX, Tumor location: Any); (T3, N0, M0, Any G, Tumor location: Unknown); (T1, N1, M0, Any G, Tumor location: Any). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133535","definition":"Stage IIB includes: (T3, N0, M0, G2-3, Tumor location: Upper/middle); (T3, N0, M0, GX, Tumor location: Any); (T3, N0, M0, Any G, Tumor location: Unknown); (T1, N1, M0, Any G, Tumor location: Any). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DA55-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A20948-DA6E-505B-E053-F662850A72D4","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438069","version":"1","preferredName":"Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438069","preferredDefinition":"Stage IIA includes: (T2, N0, M0, G2-3, Tumor location: Any); (T2, N0, M0, GX, Tumor location: Any); (T3, N0, M0, Any G, Tumor location: Lower); (T3, N0, M0, G1, Tumor location: Upper/middle). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Well-differentiated. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133534","definition":"Stage IIA includes: (T2, N0, M0, G2-3, Tumor location: Any); (T2, N0, M0, GX, Tumor location: Any); (T3, N0, M0, Any G, Tumor location: Lower); (T3, N0, M0, G1, Tumor location: Upper/middle). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Well-differentiated. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DA7B-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A20948-DA94-505B-E053-F662850A72D4","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"IB","valueDescription":"Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438071","version":"1","preferredName":"Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438071","preferredDefinition":"Stage IB includes: (T1a, N0, M0, G2-3, Tumor location: Any); (T1b, N0, M0, G1-3, Tumor location: Any); (T1b, N0, M0, GX, Tumor location: Any); (T2, N0, M0, G1, Tumor location: Any). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133530","definition":"Stage IB includes: (T1a, N0, M0, G2-3, Tumor location: Any); (T1b, N0, M0, G1-3, Tumor location: Any); (T1b, N0, M0, GX, Tumor location: Any); (T2, N0, M0, G1, Tumor location: Any). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DAA1-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A20948-DABA-505B-E053-F662850A72D4","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"IA","valueDescription":"Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438073","version":"1","preferredName":"Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438073","preferredDefinition":"Stage IA includes: (T1a, N0, M0, G1, Tumor location: Any); (T1a, N0, M0, GX, Tumor location: Any). T1a: Tumor invades the lamina propria or muscularis mucosae. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133525","definition":"Stage IA includes: (T1a, N0, M0, G1, Tumor location: Any); (T1a, N0, M0, GX, Tumor location: Any). T1a: Tumor invades the lamina propria or muscularis mucosae. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DAC7-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A20948-DAE0-505B-E053-F662850A72D4","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"},{"value":"0","valueDescription":"Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438075","version":"1","preferredName":"Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438075","preferredDefinition":"Stage 0 includes: Tis, N0, M0, GN/A, Tumor location: Any. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. GN/A: Grade non-applicable. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133519","definition":"Stage 0 includes: Tis, N0, M0, GN/A, Tumor location: Any. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. GN/A: Grade non-applicable. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DAED-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76A20948-DB06-505B-E053-F662850A72D4","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6438056","version":"1","preferredName":"Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the pathologic staging of esophageal squamous cell carcinoma according to the American Joint Committee on Cancer, 8th edition.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C133445:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage","conceptCode":"C133445","definition":"A term that refers to the pathologic staging of esophageal squamous cell carcinoma according to the American Joint Committee on Cancer, 8th edition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-D990-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"76A20948-D9A1-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"TAYLORT","dateModified":"2018-10-04","changeDescription":"10-4-18 Changed from Draft New to Released/tmt. Content reviewed and approved by requesting organization. 9/24/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6437866","version":"1","longName":"Esophagus and Esophagogastric Junction","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic disease stage","type":"Preferred Question Text","description":"Pathologic disease stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"76A3BD37-FE43-56F3-E053-F662850AE662","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"TAYLORT","dateModified":"2018-10-04","changeDescription":"10-4-18 Changed from Draft New to Released/tmt. Content reviewed and approved by requesting organization. 9/24/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}